I know -- it is TheStreet.com, talking here -- but it is intriguing (despite being a Jim Cramer property):
. . . .China Sky is set to report earnings of $2.41 a share for 2010, according to consensus estimates of analysts polled by Bloomberg. In comparison, Pfizer and Merck are likely to report earnings of $1.56 a share and $2.38 a share, respectively, for 2010. . . .
TheStreet is making the case that China's pharma companies may be a more compelling value that either Pfizer or Merck. Just so you know.